View |
|
DRP-9986-01
|
Rosuvastatin (as calcium)
|
Mayrosu
|
20 mg
|
Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 June 2024
|
08 July 2025
|
View |
|
DRP-9987
|
Nifedipine
|
Nicardia Retard 20
|
20 mg
|
Extended-Release Tablet
|
Calcium Channel Blocker
|
Unique Pharmaceutical Laboratories
(A Div of J.B Chemicals & Pharmaceuticals Limited)
|
India
|
Renewal
|
21 April 2022
|
03 July 2027
|
View |
|
DRP-9988
|
DOXYCYCLINE (AS HYCLATE)
|
Unbranded
|
100MG
|
CAPSULE
|
ANTIBACTERIAL (TETRACYCLINE)
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
Renewal
|
25 August 2022
|
13 August 2027
|
View |
|
DRP-9989
|
Icosapent Ethyl
|
Epacor
|
1g
|
Capsule
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
Initial (Correction)
|
30 June 2022
|
14 July 2026
|
View |
|
DRP-9990
|
Piracetam
|
Nurocer
|
400 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
05 July 2021
|
21 April 2025
|
View |
|
DRP-9991
|
Oxytocin
|
Gyne-Tocin
|
10 IU/mL
|
Solution For Injection I.M./I.V.)
|
POSTERIOR PITUITARY HORMONE
|
Harmann Pharmaceutical Laboratories (Pvt.) Ltd.
|
Pakistan
|
-
|
05 July 2021
|
21 April 2025
|
View |
|
DRP-9991-01
|
Oxytocin
|
Ergitocin
|
10 IU/mL
|
Solution for Injection (IM/IV)
|
-
|
Harmann Pharmaceutical Laboratories (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
17 January 2023
|
21 April 2025
|
View |
|
DRP-9993
|
Cefuroxime (As Axetil)
|
Zefuxime
|
500 mg
|
Film-Coated Tablet
|
-
|
Friends Pharma (Pvt.) Ltd,
|
Pakistan
|
-
|
05 July 2021
|
13 February 2025
|
View |
|
DRP-9993-01
|
CEFUROXIME (AS AXETIL)
|
CEFUQUEST
|
500 MG
|
FILM-COATED TABLET
|
ANTIBACTERIAL
|
FRIENDS PHARMA (PVT.) LTD.
|
Pakistan
|
CLIDP Conversion
|
08 August 2022
|
13 February 2025
|
View |
|
DRP-9994
|
Tramadol (As Hydrochloride)
|
Tramide
|
50 mg/mL
|
Solution For Injection (I.M./I.V.)
|
OPIOID ANALGESIC
|
Harmann Pharmaceutical Laboratories (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
07 March 2023
|
02 May 2028
|
View |
|
DRP-9995
|
Cefalexin (As Monohydrate)
|
Celoxone
|
500 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
05 July 2021
|
14 August 2025
|
View |
|
DRP-9995-01
|
Cefalexin (As Monohydrate)
|
Nixin
|
500 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
22 November 2021
|
14 August 2025
|
View |
|
DRP-9996
|
Ramipril
|
Ramipro
|
5 mg
|
Tablet
|
Angiotensin Converting Enzyme (ACE) Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
13 September 2021
|
26 September 2026
|
View |
|
DRP-9997
|
Digoxin
|
Fargoxin
|
250 mcg/mL (500 mcg/2 mL)
|
Solution for Injection (I.M./I.V.)
|
-
|
PT. Pratapa Nirmala
|
Indonesia
|
-
|
02 July 2021
|
02 July 2026
|
View |
|
DRP-9998
|
Ascorbic Acid + Zinc
|
VG Pak-C Plus
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate) /15 mg (equivalent to 41.2 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
-
|
19 July 2021
|
19 July 2026
|
View |
|
DRP-9999
|
Irbesartan
|
Irbezyd 300
|
300 mg
|
Film-Coated Tablet
|
Angiotensin-II Receptor Antagonist
|
Cadila Healthcare Limited
|
India
|
Automatic Renewal
|
21 April 2022
|
20 June 2027
|
View |
|
DRP-9999-01
|
Irbesartan
|
None
|
300 mg
|
Film-Coated Tablet
|
Angiontensin-II Receptor Antagonist
|
Cadila Healthcare Limited
|
India
|
Renewal
|
16 May 2022
|
20 June 2027
|
View |
|
DRP-XY37698
|
Phenylephrine Hdyrochloride + Brompheniramine Maleate
|
Hisdec (Reformulated)
|
6.25 mg/2 mg per mL
|
Syrup (Oral Drops)
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
09 October 2020
|
29 March 2025
|
View |
|
DRP-XY37698 to DR-XY37695
|
Phenylephrine Hdyrochloride + Brompheniramine Maleate
|
HISDEC (REFORMULATED)
|
6.25 mg/2 mg per mL
|
Syrup (Oral Drops)
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
09 October 2020
|
29 March 2025
|
View |
|
DRP-XY43721
|
Olanzapine
|
Olavex 10
|
10 mg
|
Tablet
|
Antipsychotic
|
AKUMS DRUGS & PHARMACEUTCALS LTD
|
India
|
Automatic Renewal
|
06 November 2023
|
12 September 2029
|